279 related articles for article (PubMed ID: 20799259)
21. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
22. Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervals.
Dilleen M; Heimann G; Hirsch I
Stat Med; 2003 Mar; 22(6):869-82. PubMed ID: 12627406
[TBL] [Abstract][Full Text] [Related]
23. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
24. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
Davis CS; Chung Y
Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
[TBL] [Abstract][Full Text] [Related]
25. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
Linden A
J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
[TBL] [Abstract][Full Text] [Related]
26. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
Lui KJ
Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
[TBL] [Abstract][Full Text] [Related]
27. Sample size for two-stage studies with maintenance therapy.
Feng W; Wahed AS
Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: an application to a randomized clinical trial of the vitamin D3.
Matsuyama Y
Stat Med; 2003 Mar; 22(5):811-27. PubMed ID: 12587107
[TBL] [Abstract][Full Text] [Related]
29. Statistical methods for active extension trials.
Hu Z; Follmann D
Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
[TBL] [Abstract][Full Text] [Related]
30. Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score.
Sugihara M
Pharm Stat; 2010; 9(1):21-34. PubMed ID: 19199275
[TBL] [Abstract][Full Text] [Related]
31. Multiple imputation analysis of case-cohort studies.
Marti H; Chavance M
Stat Med; 2011 Jun; 30(13):1595-607. PubMed ID: 21351290
[TBL] [Abstract][Full Text] [Related]
32. Multivariate Mann-Whitney estimators for the comparison of two treatments in a three-period crossover study with randomly missing data.
Kawaguchi A; Koch GG
J Biopharm Stat; 2010 Jul; 20(4):720-44. PubMed ID: 20496202
[TBL] [Abstract][Full Text] [Related]
33. Judgement post-stratification for designed experiments.
Du J; MacEachern SN
Biometrics; 2008 Jun; 64(2):345-54. PubMed ID: 17888038
[TBL] [Abstract][Full Text] [Related]
34. Interval estimation of risk ratio in the simple compliance randomized trial.
Lui KJ
Contemp Clin Trials; 2007 Feb; 28(2):120-9. PubMed ID: 16820329
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous group sequential analysis of rank-based and weighted Kaplan-Meier tests for paired censored survival data.
Andrei AC; Murray S
Biometrics; 2005 Sep; 61(3):715-20. PubMed ID: 16135022
[TBL] [Abstract][Full Text] [Related]
36. Interim analysis of binary outcome data in clinical trials: a comparison of five estimators.
Lu QS; Chow SC; Tse SK
J Biopharm Stat; 2019; 29(2):400-410. PubMed ID: 30599798
[TBL] [Abstract][Full Text] [Related]
37. Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data.
Pepe MS; Fleming TR
Biometrics; 1989 Jun; 45(2):497-507. PubMed ID: 2765634
[TBL] [Abstract][Full Text] [Related]
38. Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part I: structural nested models and marginal structural models to test and estimate treatment arm effects.
Yamaguchi T; Ohashi Y
Stat Med; 2004 Jul; 23(13):1991-2003. PubMed ID: 15211598
[TBL] [Abstract][Full Text] [Related]
39. The challenges of evaluating dose response in flexible-dose trials using marginal structural models.
Lipkovich I; Mallinckrodt CH; Faries DE
Pharm Stat; 2012; 11(6):485-93. PubMed ID: 23060290
[TBL] [Abstract][Full Text] [Related]
40. Eight interval estimators of a common rate ratio under stratified Poisson sampling.
Lui KJ
Stat Med; 2004 Apr; 23(8):1283-96. PubMed ID: 15083483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
